BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu Y, Wang L, Zhao Y, He M, Zhang X, Niu M, Feng N. Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin. International Journal of Pharmaceutics 2014;476:169-77. [DOI: 10.1016/j.ijpharm.2014.09.052] [Cited by in Crossref: 55] [Cited by in F6Publishing: 41] [Article Influence: 6.9] [Reference Citation Analysis]
Number Citing Articles
1 Zhang N, Zhang F, Xu S, Yun K, Wu W, Pan W. Formulation and evaluation of luteolin supersaturatable self-nanoemulsifying drug delivery system (S-SNEDDS) for enhanced oral bioavailability. Journal of Drug Delivery Science and Technology 2020;58:101783. [DOI: 10.1016/j.jddst.2020.101783] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
2 Outuki P, Kleinubing S, Hoscheid J, Montanha M, da Silva E, do Couto R, Kimura E, Cardoso M. The incorporation of Pterodon pubescens fruit oil into optimized nanostructured lipid carriers improves its effectiveness in colorectal cancer. Industrial Crops and Products 2018;123:719-30. [DOI: 10.1016/j.indcrop.2018.07.044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
3 Santos AED, Dal Magro C, de Britto LS, Aguiar GPS, de Oliveira JV, Lanza M. Micronization of luteolin using supercritical carbon dioxide: Characterization of particles and biological activity in vitro. The Journal of Supercritical Fluids 2022;181:105471. [DOI: 10.1016/j.supflu.2021.105471] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Kaur A, Goindi S, Katare OP. Formulation, characterisation and in vivo evaluation of lipid-based nanocarrier for topical delivery of diflunisal. Journal of Microencapsulation 2016;33:475-86. [DOI: 10.1080/02652048.2016.1216189] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
5 Olerile LD, Liu Y, Zhang B, Wang T, Mu S, Zhang J, Selotlegeng L, Zhang N. Near-infrared mediated quantum dots and paclitaxel co-loaded nanostructured lipid carriers for cancer theragnostic. Colloids and Surfaces B: Biointerfaces 2017;150:121-30. [DOI: 10.1016/j.colsurfb.2016.11.032] [Cited by in Crossref: 51] [Cited by in F6Publishing: 36] [Article Influence: 10.2] [Reference Citation Analysis]
6 Premathilaka R, Rashidinejad A, Golding M, Singh J. Oral delivery of hydrophobic flavonoids and their incorporation into functional foods: Opportunities and challenges. Food Hydrocolloids 2022;128:107567. [DOI: 10.1016/j.foodhyd.2022.107567] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
7 Elnaggar YS, Elsheikh MA, Abdallah OY. Phytochylomicron as a dual nanocarrier for liver cancer targeting of luteolin: in vitro appraisal and pharmacodynamics. Nanomedicine 2018;13:209-32. [DOI: 10.2217/nnm-2017-0220] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
8 Alam T, Khan S, Gaba B, Haider MF, Baboota S, Ali J. Adaptation of Quality by Design-Based Development of Isradipine Nanostructured–Lipid Carrier and Its Evaluation for In Vitro Gut Permeation and In Vivo Solubilization Fate. Journal of Pharmaceutical Sciences 2018;107:2914-26. [DOI: 10.1016/j.xphs.2018.07.021] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
9 Kim E, Ban C, Kim S, Lim S, Choi YJ. Applications and perspectives of polyphenol-loaded solid lipid nanoparticles and nanostructured lipid carriers for foods. Food Sci Biotechnol. [DOI: 10.1007/s10068-022-01093-0] [Reference Citation Analysis]
10 Yang L, Shuyuan S, Huang G, Yingchong C, Shen B, Yue P. Nanocrystals based mucosal delivery system: Research Advances. Drug Dev Ind Pharm 2022;:1-29. [PMID: 35287534 DOI: 10.1080/03639045.2022.2053985] [Reference Citation Analysis]
11 Harisa GI, Alomrani AH, Badran MM. Simvastatin-loaded nanostructured lipid carriers attenuate the atherogenic risk of erythrocytes in hyperlipidemic rats. European Journal of Pharmaceutical Sciences 2017;96:62-71. [DOI: 10.1016/j.ejps.2016.09.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
12 Rehman S, Nabi B, Baboota S, Ali J. Tailoring lipid nanoconstructs for the oral delivery of paliperidone: Formulation, optimization and in vitro evaluation. Chem Phys Lipids 2021;234:105005. [PMID: 33144070 DOI: 10.1016/j.chemphyslip.2020.105005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Poonia N, Kharb R, Lather V, Pandita D. Nanostructured lipid carriers: versatile oral delivery vehicle. Future Sci OA 2016;2:FSO135. [PMID: 28031979 DOI: 10.4155/fsoa-2016-0030] [Cited by in Crossref: 68] [Cited by in F6Publishing: 51] [Article Influence: 11.3] [Reference Citation Analysis]
14 Liu Q, Li J, Pu G, Zhang F, Liu H, Zhang Y. Co-delivery of baicalein and doxorubicin by hyaluronic acid decorated nanostructured lipid carriers for breast cancer therapy. Drug Delivery 2016;23:1364-8. [DOI: 10.3109/10717544.2015.1031295] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 6.6] [Reference Citation Analysis]
15 Reginald-opara JN, Attama A, Ofokansi K, Umeyor C, Kenechukwu F. Molecular interaction between glimepiride and Soluplus ® -PEG 4000 hybrid based solid dispersions: Characterisation and anti-diabetic studies. International Journal of Pharmaceutics 2015;496:741-50. [DOI: 10.1016/j.ijpharm.2015.11.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
16 Yaghmur A, Mu H. Recent advances in drug delivery applications of cubosomes, hexosomes, and solid lipid nanoparticles. Acta Pharm Sin B 2021;11:871-85. [PMID: 33996404 DOI: 10.1016/j.apsb.2021.02.013] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 30.0] [Reference Citation Analysis]
17 Subramaniam B, Siddik ZH, Nagoor NH. Optimization of nanostructured lipid carriers: understanding the types, designs, and parameters in the process of formulations. J Nanopart Res 2020;22. [DOI: 10.1007/s11051-020-04848-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
18 Wang C, Sun X, Wang K, Wang Y, Yang F, Wang H. Breast cancer targeted chemotherapy based on doxorubicin-loaded bombesin peptide modified nanocarriers. Drug Delivery 2016;23:2697-702. [DOI: 10.3109/10717544.2015.1049721] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
19 Miyashita A, Ito J, Parida IS, Syoji N, Fujii T, Takahashi H, Nakagawa K. Improving water dispersibility and bioavailability of luteolin using microemulsion system. Sci Rep 2022;12:11949. [PMID: 35831358 DOI: 10.1038/s41598-022-16220-4] [Reference Citation Analysis]
20 Sartaj A, Annu, Alam M, Biswas L, Yar MS, Mir SR, Verma AK, Baboota S, Ali J. Combinatorial delivery of Ribociclib and Green tea extract mediated nanostructured lipid carrier for oral delivery for the treatment of breast cancer synchronizing in silico, in vitro, and in vivo studies. J Drug Target 2022;:1-31. [PMID: 35856926 DOI: 10.1080/1061186X.2022.2104292] [Reference Citation Analysis]
21 Francisco V, Figueirinha A, Costa G, Liberal J, Ferreira I, Lopes MC, García-rodríguez C, Cruz MT, Batista MT. The Flavone Luteolin Inhibits Liver X Receptor Activation. J Nat Prod 2016;79:1423-8. [DOI: 10.1021/acs.jnatprod.6b00146] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
22 Omari-Siaw E, Wang Q, Sun C, Gu Z, Zhu Y, Cao X, Firempong CK, Agyare R, Xu X, Yu J. Tissue distribution and enhanced in vivo anti-hyperlipidemic-antioxidant effects of perillaldehyde-loaded liposomal nanoformulation against Poloxamer 407-induced hyperlipidemia. Int J Pharm 2016;513:68-77. [PMID: 27567929 DOI: 10.1016/j.ijpharm.2016.08.042] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
23 Ott C, Lacatusu I, Badea G, Grafu IA, Istrati D, Babeanu N, Stan R, Badea N, Meghea A. Exploitation of amaranth oil fractions enriched in squalene for dual delivery of hydrophilic and lipophilic actives. Industrial Crops and Products 2015;77:342-52. [DOI: 10.1016/j.indcrop.2015.08.057] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
24 Lacatusu I, Badea N, Badea G, Brasoveanu L, Stan R, Ott C, Oprea O, Meghea A. Ivy leaves extract based – lipid nanocarriers and their bioefficacy on antioxidant and antitumor activities. RSC Adv 2016;6:77243-55. [DOI: 10.1039/c6ra12016d] [Cited by in Crossref: 11] [Article Influence: 1.8] [Reference Citation Analysis]
25 Siddique YH. Role of luteolin in overcoming Parkinson's disease. Biofactors 2021;47:198-206. [PMID: 33443305 DOI: 10.1002/biof.1706] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Kim BS, Na YG, Choi JH, Kim I, Lee E, Kim SY, Lee JY, Cho CW. The Improvement of Skin Whitening of Phenylethyl Resorcinol by Nanostructured Lipid Carriers. Nanomaterials (Basel) 2017;7:E241. [PMID: 28846658 DOI: 10.3390/nano7090241] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
27 El-lakany SA, Elgindy NA, Helmy MW, Abu-serie MM, Elzoghby AO. Lactoferrin-decorated vs PEGylated zein nanospheres for combined aromatase inhibitor and herbal therapy of breast cancer. Expert Opinion on Drug Delivery 2018;15:835-50. [DOI: 10.1080/17425247.2018.1505858] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
28 Beloqui A, del Pozo-rodríguez A, Isla A, Rodríguez-gascón A, Solinís MÁ. Nanostructured lipid carriers as oral delivery systems for poorly soluble drugs. Journal of Drug Delivery Science and Technology 2017;42:144-54. [DOI: 10.1016/j.jddst.2017.06.013] [Cited by in Crossref: 32] [Cited by in F6Publishing: 14] [Article Influence: 6.4] [Reference Citation Analysis]
29 Baghel S, Cathcart H, O’reilly NJ. Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System. Mol Pharmaceutics 2018;15:3796-812. [DOI: 10.1021/acs.molpharmaceut.8b00306] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
30 Rohmah M, Raharjo S, Hidayat C, Martien R. Application of Response Surface Methodology for the Optimization of β‐Carotene‐Loaded Nanostructured Lipid Carrier from Mixtures of Palm Stearin and Palm Olein. J Am Oil Chem Soc 2019;97:213-23. [DOI: 10.1002/aocs.12310] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Wang L, Zhong C, Zu Y, Zhao X, Deng Y, Wu W, Sun X, Wang L, Wu M. Preparation and characterization of luteolin nanoparticles for enhance bioavailability and inhibit liver microsomal peroxidation in rats. Journal of Functional Foods 2019;55:57-64. [DOI: 10.1016/j.jff.2019.01.054] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
32 Otarola J, Garrido M, Correa NM, Molina PG. Square Wave Voltammetry: An Alternative Technique to Determinate Piroxicam Release Profiles from Nanostructured Lipid Carriers. ChemPhysChem 2016;17:2322-8. [DOI: 10.1002/cphc.201600226] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
33 Beloqui A, Solinís MÁ, Rodríguez-gascón A, Almeida AJ, Préat V. Nanostructured lipid carriers: Promising drug delivery systems for future clinics. Nanomedicine: Nanotechnology, Biology and Medicine 2016;12:143-61. [DOI: 10.1016/j.nano.2015.09.004] [Cited by in Crossref: 290] [Cited by in F6Publishing: 249] [Article Influence: 48.3] [Reference Citation Analysis]
34 Kaur G, Mehta SK, Kumar S, Bhanjana G, Dilbaghi N. Coencapsulation of hydrophobic and hydrophilic antituberculosis drugs in synergistic Brij 96 microemulsions: a biophysical characterization. J Pharm Sci 2015;104:2203-12. [PMID: 25951802 DOI: 10.1002/jps.24469] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
35 Santiago RR, Gyselle de Holanda e Silva K, Dantas dos Santos N, Genre J, Freitas de Oliveira Lione V, Silva AL, Marcelino HR, Gondim AD, Tabosa do Egito ES. Nanostructured lipid carriers containing Amphotericin B: Development, in vitro release assay, and storage stability. Journal of Drug Delivery Science and Technology 2018;48:372-82. [DOI: 10.1016/j.jddst.2018.10.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
36 Alpsoy L, Baykal A, Akal ZÜ. Luteolin-Loaded Spion as a Drug Carrier for Cancer Cell In Vitro. J Supercond Nov Magn 2018;31:467-74. [DOI: 10.1007/s10948-017-4199-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
37 Moldes ÓA, Cid A, Montoya IA, Mejuto JC. Linear Polyethers as Additives for AOT-Based Microemulsions: Prediction of Percolation Temperature Changes Using Artificial Neural Networks. Tenside Surfactants Detergents 2015;52:264-70. [DOI: 10.3139/113.110374] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Chen P, Wu M, Chang H, Tai M, Ho C, Yen J. Up-Regulation of miR-34a Expression in Response to the Luteolin-Induced Neurite Outgrowth of PC12 Cells. J Agric Food Chem 2015;63:4148-59. [DOI: 10.1021/acs.jafc.5b01005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
39 Mehmood S, Uddin MA, Yu H, Wang L, Amin BU, Haq F, Fahad S, Haroon M. Study on synthesis of cross-linked poly(cyclotriphosphazene-co-luteolin) nanospheres and their properties for controlled drug delivery. Colloid Polym Sci. [DOI: 10.1007/s00396-022-04992-0] [Reference Citation Analysis]
40 Godugu C, Doddapaneni R, Safe SH, Singh M. Novel diindolylmethane derivatives based NLC formulations to improve the oral bioavailability and anticancer effects in triple negative breast cancer. Eur J Pharm Biopharm 2016;108:168-79. [PMID: 27586082 DOI: 10.1016/j.ejpb.2016.08.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
41 Kim DS, Choi JS, Kim DW, Kim KS, Seo YG, Cho KH, Kim JO, Yong CS, Youn YS, Lim SJ, Jin SG, Choi HG. Comparison of solvent-wetted and kneaded l-sulpiride-loaded solid dispersions: Powder characterization and in vivo evaluation. Int J Pharm 2016;511:351-8. [PMID: 27397868 DOI: 10.1016/j.ijpharm.2016.07.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
42 Salvi VR, Pawar P. Nanostructured lipid carriers (NLC) system: A novel drug targeting carrier. Journal of Drug Delivery Science and Technology 2019;51:255-67. [DOI: 10.1016/j.jddst.2019.02.017] [Cited by in Crossref: 60] [Cited by in F6Publishing: 24] [Article Influence: 20.0] [Reference Citation Analysis]
43 Wu G, Li J, Yue J, Zhang S, Yunusi K. Liposome encapsulated luteolin showed enhanced antitumor efficacy to colorectal carcinoma. Mol Med Rep 2018;17:2456-64. [PMID: 29207088 DOI: 10.3892/mmr.2017.8185] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
44 Yu Q, Hu X, Ma Y, Xie Y, Lu Y, Qi J, Xiang L, Li F, Wu W. Lipids-based nanostructured lipid carriers (NLCs) for improved oral bioavailability of sirolimus. Drug Delivery 2016;23:1469-75. [DOI: 10.3109/10717544.2016.1153744] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
45 Mu H, Holm R. Solid lipid nanocarriers in drug delivery: characterization and design. Expert Opinion on Drug Delivery 2018;15:771-85. [DOI: 10.1080/17425247.2018.1504018] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 6.8] [Reference Citation Analysis]
46 Wei Q, Yang Q, Wang Q, Sun C, Zhu Y, Niu Y, Yu J, Xu X. Formulation, Characterization, and Pharmacokinetic Studies of 6-Gingerol-Loaded Nanostructured Lipid Carriers. AAPS PharmSciTech 2018;19:3661-9. [PMID: 30324361 DOI: 10.1208/s12249-018-1165-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
47 Massimini M, Dalle Vedove E, Bachetti B, Di Pierro F, Ribecco C, D'Addario C, Pucci M. Polyphenols and Cannabidiol Modulate Transcriptional Regulation of Th1/Th2 Inflammatory Genes Related to Canine Atopic Dermatitis. Front Vet Sci 2021;8:606197. [PMID: 33763461 DOI: 10.3389/fvets.2021.606197] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
48 Taheri Y, Sharifi-Rad J, Antika G, Yılmaz YB, Tumer TB, Abuhamdah S, Chandra S, Saklani S, Kılıç CS, Sestito S, Daştan SD, Kumar M, Alshehri MM, Rapposelli S, Cruz-Martins N, Cho WC. Paving Luteolin Therapeutic Potentialities and Agro-Food-Pharma Applications: Emphasis on In Vivo Pharmacological Effects and Bioavailability Traits. Oxid Med Cell Longev 2021;2021:1987588. [PMID: 34594472 DOI: 10.1155/2021/1987588] [Reference Citation Analysis]
49 Makhdoomi S, Mahboobian MM, Haddadi R, Komaki A, Mohammadi M. Silibinin-loaded nanostructured lipid carriers (NLCs) ameliorated cognitive deficits and oxidative damages in aluminum chloride-induced neurotoxicity in male mice. Toxicology 2022;477:153260. [PMID: 35850386 DOI: 10.1016/j.tox.2022.153260] [Reference Citation Analysis]
50 Ashkar A, Sosnik A, Davidovich-Pinhas M. Structured edible lipid-based particle systems for oral drug-delivery. Biotechnol Adv 2021;:107789. [PMID: 34186162 DOI: 10.1016/j.biotechadv.2021.107789] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
51 Tawornchat P, Pattarakankul T, Palaga T, Intasanta V, Wanichwecharungruang S. Polymerized Luteolin Nanoparticles: Synthesis, Structure Elucidation, and Anti-Inflammatory Activity. ACS Omega 2021;6:2846-55. [PMID: 33553902 DOI: 10.1021/acsomega.0c05142] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
52 Sartaj A, Annu, Biswas L, Verma AK, Sahoo PK, Baboota S, Ali J, Jain S. Ribociclib Nanostructured Lipid Carrier Aimed for Breast Cancer: Formulation Optimization, Attenuating In Vitro Specification, and In Vivo Scrutinization. BioMed Research International 2022;2022:1-24. [DOI: 10.1155/2022/6009309] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
53 Nayak K, Misra M. PEGylated microemulsion for dexamethasone delivery to posterior segment of eye. J Biomater Sci Polym Ed 2020;31:1071-90. [PMID: 32149562 DOI: 10.1080/09205063.2020.1740964] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
54 Luo Q, Yang J, Xu H, Shi J, Liang Z, Zhang R, Lu P, Pu G, Zhao N, Zhang J. Sorafenib-loaded nanostructured lipid carriers for topical ocular therapy of corneal neovascularization: development, in-vitro and in vivo study. Drug Delivery 2022;29:837-55. [DOI: 10.1080/10717544.2022.2048134] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]